Ellevest’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Buy
1,963
+110
+6% +$65.3K 0.15% 95
2026
Q2
$931K Sell
1,853
-90
-5% -$43.2K 0.11% 133
2026
Q1
$955K Sell
1,943
-212
-10% -$115K 0.13% 107
2025
Q4
$1.25M Sell
2,155
-95
-4% -$53.7K 0.17% 81
2025
Q3
$1.09M Buy
2,250
+433
+24% +$202K 0.16% 98
2025
Q2
$737K Buy
1,817
+272
+18% +$114K 0.12% 130
2025
Q1
$769K Buy
1,545
+188
+14% +$102K 0.05% 129
2024
Q4
$706K Buy
1,357
+70
+5% +$38.5K 0.04% 146
2024
Q3
$796K Sell
1,287
-38
-3% -$22.5K 0.04% 138
2024
Q2
$733K Buy
1,325
+57
+4% +$32.7K 0.04% 139
2024
Q1
$737K Buy
1,268
+756
+148% +$424K 0.05% 141
2023
Q4
$272K Buy
512
+54
+12% +$26.1K 0.02% 312
2023
Q3
$232K Sell
458
-33
-7% -$17.6K 0.02% 308
2023
Q2
$256K Sell
491
-74
-13% -$39.9K 0.02% 295
2023
Q1
$326K Sell
565
-837
-60% -$472K 0.03% 224
2022
Q4
$772K Sell
1,402
-99
-7% -$52.5K 0.07% 75
2022
Q3
$761K Buy
1,501
+123
+9% +$68.8K 0.07% 62
2022
Q2
$749K Sell
1,378
-175
-11% -$96.3K 0.07% 69
2022
Q1
$917K Buy
1,553
+339
+28% +$195K 0.08% 60
2021
Q4
$810K Buy
1,214
+28
+2% +$17.5K 0.07% 64
2021
Q3
$678K Sell
1,186
-16
-1% -$8.78K 0.07% 72
2021
Q2
$606K Buy
1,202
+195
+19% +$92K 0.06% 74
2021
Q1
$460K Buy
1,007
+126
+14% +$60.1K 0.06% 87
2020
Q4
$410K Buy
881
+183
+26% +$85.8K 0.06% 77
2020
Q3
$308K Buy
698
+113
+19% +$46.7K 0.06% 94
2020
Q2
$212K Buy
585
+163
+39% +$54.6K 0.05% 111
2020
Q1
$120K Buy
422
+157
+59% +$49.5K 0.03% 122
2019
Q4
$86K Buy
265
+163
+160% +$49.4K 0.02% 120
2019
Q3
$30K Buy
102
+7
+7% +$2K 0.01% 158
2019
Q2
$28K Buy
95
+55
+138% +$15.1K 0.01% 179
2019
Q1
$11K Hold
40
– – 0.01% 187
2018
Q4
$9K Buy
+40
New +$9.38K ﹤0.01% 387

Other funds holding TMO

Ellevest's TMO Position: Q3 2026 in Review

Ellevest increased its Thermo Fisher Scientific (TMO) stake by 5.9% in Q3 2026, buying an estimated $65.3K and bringing the position to 1,963 shares worth $1.32M. The position accounts for 0.15% of the portfolio, ranked #95.

Ellevest first reported a position in TMO in Q4 2018 and has held it in 32 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Ellevest held 1,963 shares of Thermo Fisher Scientific worth $1.32M as of Q3 2026.
  • Ellevest bought 110 Thermo Fisher Scientific shares in Q3 2026, an estimated $65.3K.
  • Thermo Fisher Scientific made up 0.15% of Ellevest's portfolio in Q3 2026, its #95 holding.
  • Ellevest first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 32 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.